Thalidomide-NH-C4-NH-Boc
CAS No. 2093388-52-2
Thalidomide-NH-C4-NH-Boc ( —— )
Catalog No. M23941 CAS No. 2093388-52-2
Thalidomide-NH-C4-NH-Boc is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 97 | In Stock |
|
10MG | 151 | In Stock |
|
25MG | 305 | In Stock |
|
50MG | 462 | In Stock |
|
100MG | 672 | In Stock |
|
500MG | 1404 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThalidomide-NH-C4-NH-Boc
-
NoteResearch use only, not for human use.
-
Brief DescriptionThalidomide-NH-C4-NH-Boc is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
-
DescriptionThalidomide-NH-C4-NH-Boc is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
-
Synonyms——
-
PathwayPROTACs
-
TargetE3 Ligase Ligand
-
RecptorCereblon
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2093388-52-2
-
Formula Weight444.5
-
Molecular FormulaC22H28N4O6
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (112.49 mM; Need ultrasonic)
-
SMILESCC(C)(C)OC(=O)NCCCCNC1=CC=CC2=C1C(=O)N(C2=O)C3CCC(=O)NC3=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jiang F, et al.Discovery of novel small molecule induced selective degradation of the bromodomain and extra-terminal (BET) bromodomain protein BRD4 and BRD2 with cellular potencies.Bioorg Med Chem. 2020 Jan 1;28(1):115181.
molnova catalog
related products
-
E3 Ligand-Linker Con...
E3 Ligand-Linker Conjugate 1 is an E3 ligand- Linker Conjugate for PROTAC.
-
E3 Ligand-Linker Con...
An E3 ligase ligand-linker conjugate for PROTAC.
-
PROTAC-VHL-ligand hy...
PROTAC-VHL-ligand is a von Hippel–Lindau (VHL) ligand used for the proteolysis targeting chimeras (PROTACs) method, induces target protein degradation.